Foresite Capital Fund IV, L.P.
Related Filers (25)
- Foresite Capital Management IV, LLC (20)
- Tananbaum James B. (15)
- AERIE PHARMACEUTICALS INC (12)
- Foresite Capital Management III, LLC (10)
- Foresite Capital Fund III, L.P. (10)
- Foresite Capital Management II, LLC (9)
- Foresite Capital Fund II, L.P. (9)
- Kinnate Biopharma Inc. (8)
- Foresite Capital Management V, LLC (7)
- Foresite Capital Fund V, L.P. (7)
- Foresite Capital Opportunity Management V, LLC (5)
- Foresite Capital Opportunity Fund V, L.P. (5)
- Aclaris Therapeutics, Inc. (4)
- Pharvaris N.V. (4)
- Nurix Therapeutics, Inc. (3)
- Fulcrum Therapeutics, Inc. (3)
- Arbutus Biopharma Corp (3)
- Keros Therapeutics, Inc. (3)
- Turning Point Therapeutics, Inc. (2)
- OptiNose, Inc. (2)
- Quantum-Si Inc (2)
- Lyell Immunopharma, Inc. (2)
- Foresite Capital Fund I, L.P. (1)
- 10x Genomics, Inc. (1)
- Foresite Capital Management I, LLC (1)
- Show More ...
Ownership (49)
SC 13G/A
Tuesday, 2/13/2024
Aclaris Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
Pharvaris N.V.: Major Shareholders
4
Wednesday, 5/10/2023
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 5/10/2023
Kinnate Biopharma Inc.: Major Shareholders
4
Wednesday, 2/22/2023
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 2/22/2023
Kinnate Biopharma Inc.: Major Shareholders
SC 13G/A
Monday, 2/13/2023
Lyell Immunopharma, Inc.: Major Shareholders
SC 13G/A
Monday, 2/13/2023
Aclaris Therapeutics, Inc.: Major Shareholders
SC 13G/A
Monday, 2/13/2023
Pharvaris N.V.: Major Shareholders
SC 13D/A
Tuesday, 6/28/2022
Quantum-Si Inc: Major Shareholders
SC 13G/A
Friday, 2/11/2022
Nurix Therapeutics, Inc.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
Keros Therapeutics, Inc.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
Pharvaris N.V.: Major Shareholders
SC 13G
Friday, 2/11/2022
Lyell Immunopharma, Inc.: Major Shareholders
4
Wednesday, 11/3/2021
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Monday, 6/21/2021
Quantum-Si Inc: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Nurix Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Fulcrum Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Keros Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Arbutus Biopharma Corp: Major Shareholders
SC 13G
Friday, 2/12/2021
Pharvaris N.V.: Major Shareholders
3
Wednesday, 2/10/2021
Aclaris Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13D
Tuesday, 12/15/2020
Kinnate Biopharma Inc.: Major Shareholders
4
Wednesday, 12/9/2020
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/4/2020
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 12/3/2020
Kinnate Biopharma Inc.: Initial statement of beneficial ownership of securities
SC 13G
Monday, 8/3/2020
Nurix Therapeutics, Inc.: Major Shareholders
SC 13G
Wednesday, 4/15/2020
Keros Therapeutics, Inc.: Major Shareholders
4
Monday, 3/2/2020
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 2/14/2020
Turning Point Therapeutics, Inc.: Major Shareholders
SC 13G/A
Friday, 2/14/2020
Arbutus Biopharma Corp: Major Shareholders
SC 13G/A
Friday, 2/14/2020
OptiNose, Inc.: Major Shareholders
SC 13G/A
Friday, 2/14/2020
Fulcrum Therapeutics, Inc.: Major Shareholders
4
Monday, 12/23/2019
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 12/9/2019
Arbutus Biopharma Corp: Major Shareholders
4
Thursday, 12/5/2019
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Monday, 11/18/2019
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/12/2019
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3/A
Tuesday, 11/5/2019
AERIE PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
3
Wednesday, 9/11/2019
10x Genomics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 9/6/2019
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/4/2019
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Friday, 8/23/2019
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/20/2019
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3
Wednesday, 8/14/2019
AERIE PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
4
Wednesday, 8/14/2019
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 7/29/2019
Fulcrum Therapeutics, Inc.: Major Shareholders
SC 13G
Thursday, 5/2/2019
Turning Point Therapeutics, Inc.: Major Shareholders
SC 13G
Thursday, 3/14/2019
OptiNose, Inc.: Major Shareholders